Regulatory Workflows and Interactions - pharma, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/APIX---API-Exchange-for-Medicinal-Products/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
{
"resourceType" : "Task",
"id" : "scenario4-05-labelling-comments-round1-response",
"meta" : {
"versionId" : "2",
"lastUpdated" : "2027-03-01T16:30:00+01:00",
"profile" : [
🔗 "http://hl7.org/fhir/uv/apix/StructureDefinition/apix-task"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Counter-proposal received (round 1)</b></p><table class=\"grid\"><tr><th>Task</th><td>Labelling Comments (<code>labelling-comments</code>)</td></tr><tr><th>Procedure number</th><td>VAR-II-2027-0012</td></tr><tr><th>Version</th><td>2</td></tr><tr><th>Status</th><td>completed</td></tr><tr><th>Business status</th><td>Counter-Proposal Received (<code>counter-proposal-received</code>)</td></tr><tr><th>Requester</th><td>Health Authority – Regulatory Review Division</td></tr><tr><th>Owner</th><td>SynthPharma AG</td></tr><tr><th>Group identifier</th><td>urn:uuid:60ac55b8-8d46-58ff-b1b2-e8015d4960be</td></tr><tr><th>Authored</th><td>2027-02-22T10:00:00+01:00</td></tr><tr><th>Last modified</th><td>2027-03-01T16:30:00+01:00</td></tr><tr><th>Based on</th><td><a href=\"Task-scenario4-01-variation-submitted.html\">scenario4-01-variation-submitted</a></td></tr><tr><th>Response due</th><td>2027-03-04T23:59:59+01:00</td></tr></table><p><b>Inputs (from the requester)</b></p><ul><li><a href=\"DocumentReference-docref-epi-annotated-v2.html\">Annotated ePI v2 (regulator comments, round 1)</a> <code>labelling-comments</code></li></ul><p><b>Outputs (from the owner)</b></p><ul><li><a href=\"DocumentReference-docref-epi-annotated-v3.html\">Annotated ePI v3 (counter-proposal, round 1)</a> <code>proposed-labelling</code></li><li><a href=\"DocumentReference-docref-epi-clean-v3.html\">Clean ePI v3 (counter-proposal, round 1)</a> <code>epi-bundle</code></li></ul></div>"
},
"identifier" : [
{
"use" : "official",
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/apix/CodeSystem/apix-demo",
"code" : "apixtaskinstance",
"display" : "APIX Task Instance ID"
}
]
},
"system" : "http://example.org/health-authority/task-id",
"value" : "urn:uuid:8d04eb3f-cad1-5a30-aa90-894f6ea36577"
},
{
"use" : "official",
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/apix/CodeSystem/apix-demo",
"code" : "apixregulatorprocedureno",
"display" : "APIX Regulator Procedure Number"
}
]
},
"system" : "http://example.org/health-authority/procedure-number",
"value" : "VAR-II-2027-0012"
}
],
"basedOn" : [
{
🔗 "reference" : "Task/scenario4-01-variation-submitted"
}
],
"groupIdentifier" : {
"use" : "official",
"system" : "http://example.org/health-authority/work-flow-group-id",
"value" : "urn:uuid:60ac55b8-8d46-58ff-b1b2-e8015d4960be"
},
"status" : "completed",
"businessStatus" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/apix/CodeSystem/apix-business-status",
"code" : "counter-proposal-received",
"display" : "Counter-Proposal Received"
}
]
},
"intent" : "proposal",
"priority" : "routine",
"code" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/apix/CodeSystem/apix-task-code",
"code" : "labelling-comments",
"display" : "Labelling Comments"
}
]
},
"requestedPeriod" : {
"start" : "2027-02-22T10:00:00+01:00",
"end" : "2027-03-04T23:59:59+01:00"
},
"executionPeriod" : {
"start" : "2027-02-22T10:20:00+01:00",
"end" : "2027-03-01T16:30:00+01:00"
},
"authoredOn" : "2027-02-22T10:00:00+01:00",
"lastModified" : "2027-03-01T16:30:00+01:00",
"requester" : {
🔗 "reference" : "Organization/org-ema-srm-hmed",
"display" : "Health Authority – Regulatory Review Division"
},
"owner" : {
🔗 "reference" : "Organization/org-synthpharma-ag",
"display" : "SynthPharma AG"
},
"input" : [
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/apix/CodeSystem/apix-task-input-output-type",
"code" : "labelling-comments",
"display" : "Labelling Comments"
}
]
},
"valueReference" : {
🔗 "reference" : "DocumentReference/docref-epi-annotated-v2",
"display" : "Annotated ePI v2 (regulator comments, round 1)"
}
}
],
"output" : [
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/apix/CodeSystem/apix-task-input-output-type",
"code" : "proposed-labelling",
"display" : "Proposed Labelling"
}
]
},
"valueReference" : {
🔗 "reference" : "DocumentReference/docref-epi-annotated-v3",
"display" : "Annotated ePI v3 (counter-proposal, round 1)"
}
},
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/apix/CodeSystem/apix-task-input-output-type",
"code" : "epi-bundle",
"display" : "ePI Bundle"
}
]
},
"valueReference" : {
🔗 "reference" : "DocumentReference/docref-epi-clean-v3",
"display" : "Clean ePI v3 (counter-proposal, round 1)"
}
}
]
}